.png)
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.
Key areas of focus are inflammation and genetic diseases. We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners.
These are our products on the Uniform Formulary and VA National Formulary:
DOPTELET (avatrombopag)
VONJO (pacritinib)